Medical articles today

/* 728x15, */

1.9m To Tackle The Grand Confrontation In Nanotechnology For Healthcare, UK

/* 468x60, */

A multidisciplinary side of scientists at Swansea University has been awarded a large-scale grant by the Engineering and Physical Sciences Research Council (EPSRC) to directions a Grand Challenge in the application of Nanotechnology to Healthcare. The team's project was ranked first in the UK - in the EPSRC's precedence order for funding - and has been awarded 1.9million over a period of three years.
Professor Rhodri Williams, Lead Investigator of the EPSRC Portfolio Partnership in Heterogeneous Fluids and Complex Flows at Swansea University's School of Engineering, who leads the Swansea Grand Challenge club said:
"Our aim is to improve the sensitivity of early clot detection. This will allow extended accurate assessment of abnormalities and the targeting of clots at the earliest episode of development. The project team, drawn from Swansea University's School of Engineering, Institute of Medicine and Faculty of Physical Science's Machine Science department, will address thromboembolic disease and associated blood coagulation abnormalities that cause significant disease and darkness in Western society."
Vise Chancellor of Swansea University, Professor Richard B Davies, said: "It is also evidence that Swansea University is at once playing in the probation premier league. More than that, this project shows that we have an established label for proof which makes a difference.
"This is a highly prestigious award achieved in competition with some of the chief test minds in the UK. Moreover, success generates success: awards such as these authorize us to forge ahead to attract the best students and staff to our University."
The Grand Trial in Nanotechnology for Healthcare project testament exploit advances in blood clot detection, already made under Professor Williams' Regal Society Brian Mercer Award, by linking this bullwork with the ultra-sensitive nanomaterials evolving existence undertaken at Swansea University's Multidisciplinary Nanotechnology Centre. As such, the project will assign the foundations for a 'Point of Care (POC)' diagnostic manner that, eventually, will care at-risk patients with a safe and easy-to-use slogan for monitoring of clots. The Clinical Haemorheology Laboratory located at the ABM University NHS Trust's Morriston Hospital, is a key part of this aspect of the project.
The project will also provide a new technological grounds for thromboembolic disease screening. Thromboembolism is the formation in a blood vessel of a clot (thrombus) that breaks loose and is carried by the blood stream to plug another vessel. The clot may plug a vessel in the lungs (pulmonary embolism), brain (stroke), gastrointestinal tract, kidneys, or leg.
The outfit draws on a tremendous breadth of expertise in nanosensors (Professor Steve Wilks, Professor Huw Summers, Dr Thierry Maffeis and Dr Owen Guy), human-device interplay (Professor Harold Thimbleby), printing technologies (Dr Tim Claypole), surface characterization (Dr Chris Wright), biopolymer rheology (Dr Karl Hawkins) and blood coagulation (Dr Adrian Evans). Dr. Matthew Barrow will focus on the rheometrical aspects while Dr Point Penny will grow up the nanosensors incorporated within the location of interest device.
The project also involves collaboration with experts in narcotic delivery analysis at the University of London's Academy of Pharmacy. Professor Kostas Kostarelos, who leads the team at the University of London, said: "The Swansea-London duo is hoping to translate convincing nanotechnologies and reap benefits against one of the major killer pathologies in our society. Any incremental improvement we can approach for the diagnosis, treatment and monitoring of stroke will be an achievement."
To help american man and benefit the project team, an International Advisory Panel is duration established with UK representatives including Professor Marc Clement, Honorary Chair of Medical Innovation at Swansea University, and Professor Stephen Bain, Director of Trial at the ABMU NHS Trust.
- Swansea University is a world-class, research-led university situated in stunning parkland overlooking Swansea Bay on the string of the Gower peninsula, the UK's first Earth of Outstanding Constant Beauty. Founded in 1920, the University instantly offers around 500 student courses and 150 postgraduate courses to else than 13,800 students.
- Swansea University's School of Engineering is one of the meaningful Engineering Schools in the UK, as recognised by the cool performance in the recent Evaluation Assessment Exercise - where the Multidisciplinary Nanotechnology Middle (MNC) was ranked 5th in the UK out of 52 institutions submitted to the General Engineering category. Eighty percent of the staff were rated as internationally important or internationally excellent. This mirrors excellent' rated teaching for the School's undergraduate and postgraduate courses which are state-of-the-art and bedding the changing needs of the industry. The College has an international reputation for innovation and developing au courant technologies designed to bring about a valid deviation to people's lives. For further information, please visit:
- Established in 2001, Swansea University's Institution of Medicine aim to be a centre of excellence in world-class research and medical education has been recently boosted by scoring over 50% for internationally relevant or internationally excellent research in the 2008 Check Assessment Operate and the award of the filled Graduate Entry Medicine measure from the September 2009 undergraduate intake. For too information, please visit:
- The School of Physical Sciences at Swansea University is home to world-class researchers and facilities, and admirable research-led degree programmes in Personal computer Science, Mathematics and Physics. For very information, please visit:
- ABM University NHS Trust is the largest in Wales; with 16,000 staff covering a population of 600,000 across Swansea; Neath Harbour Talbot, Bridgend and the Western Vale of Glamorgan. For further information, please visit:
- The University of London's School of Pharmacy is the lone free-standing specialist school in the UK dedicated entirely to teaching and research in drugstore and pharmaceutical sciences; with world-class teaching and a top rated research constitution profile. Its mission is to advance in education, research and policy development that benefits patients and healthcare practice, medicines discovery and development, and society; focusing on four crucial areas - Drug Discovery, Formulation Sciences, Neuroscience, and Medicines Bag and Health; and assist fashion new areas of significance, such as Behavioural Medicine, Pediatric Pharmacy, Gene Therapy and Nanomedicine. In the 2008 Research Assessment Application for British universities, 65 per cent of research life at The School of Pharmacy has been deemed 4* and 3*, allusion that this is regarded as world-leading or internationally excellent. For further information, please visit:
- The EPSRC Grand Challenge is a societal or economic occupation to which science must be applied in distribution to accelerate success in relation to solutions and accomplish a significant impact. This will allow the UK research district customary goals to assignment towards, goals that objective to produce the UK absolutely world leading in these areas.
Engineering and Physical Sciences Research Council
/* 468x60, */


university, swansea university, university nhs, university professor, abm university, university academy, university home, university playing, university grand, university london
/* 160x600, */
Medical articles today © Padayatra Dmitriy
Designer Dimitrov Dmytriy